Occasionally, clinicians are presented with a complicated preterm pregnancy where fetal pulmonary maturity testing might be used to help guide management decisions. However, should delivery be allowed if the lecithin to sphingomyelin ratio (L /S ratio) is not quite mature? The incidence of newborn complications after delivery with L /S ratio values of 1.8 and 1.9 is unknown. The purpose of this study was to evaluate the neonatal morbidity and mortality in patients that delivered with these borderline immature results.
When managing a complicated preterm pregnancy, one potential approach that a clinician might choose is to assess fetal pulmonary maturity. If the testing reveals that the fetus is mature, the delivery can be performed or, at the very least, the prevention of delivery can often be discontinued. If the test results indicate that the fetus may not be mature, attempts at preventing delivery are often considered.
Many different types of fetal pulmonary maturity tests are available on the market today. These have usually been compared with the lecithin to sphingomyelin ratio (L/S ratio). This test was originally described by Gluck et al. 1 and is still one of the major tests for assessing fetal pulmonary maturity. There are numerous studies in agreement with the fact that there is minimal neonatal morbidity or mortality after delivery of an infant with an L/S ratio of Ն2.0. [2] [3] [4] However, a value of Ͻ2.0 is not always predictive that the newborn will have difficulty.
Occasionally, a clinician may be confronted with an L/S ratio value of 1.8 or 1.9 while managing a preterm pregnant mother who is currently stable but who has the potential to become unstable at any time. In this situation, it is unclear what neonatal risks actually accompany these "borderline immature" values. Therefore the purpose of our study was to collect a series of patients who delivered in the face of an L/S ratio of 1.8 or 1.9 and assess the newborn outcome.
METHODS
All patients who underwent fetal pulmonary maturity testing at Long Beach Memorial Women's Hospital during a 9-year period (1987 to 1995) were prospectively recorded in log books. Long Beach Memorial Women's Hospital is considered to be a perinatal tertiary care referral center. Only patients with singleton pregnancies of Ͻ37 weeks' gestation who had L/S ratios of 1.8 or 1.9 were selected.
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Subjects were excluded if there was contamination of the amniotic fluid with blood or meconium, delivery Ͼ72 hours after testing, severe fetal anomalies incompatible with life, or delivery at another institution. All amniotic fluid samples were obtained by transabdominal amniocentesis for clinical indications using a standard sterile technique. The L/S ratio was determined using thin-layer chromatography as described by Gluck et al. 1 In brief, amniotic fluid was centrifuged at 1000 ϫ g for 5 minutes. The supernatant was then mixed with methanol and chloroform. The chloroform layer was evaporated twice at 60°C, and the surface active fraction of lecithin was separated and precipitated with acetone. Aliquots were then run on thinlayer chromatography silica gel. The test results were considered mature in our laboratory if the L/S ratio was Ն2.0.
The maternal factors recorded were gestational age at amniocentesis, gestational age at delivery, use of antenatal steroids, and indication for amniocentesis, which included preterm premature rupture of membranes, preterm labor, chronic hypertension, pregnancy-induced hypertension, placenta previa, abruptio placentae, systemic lupus erythematosis, diabetes, fetal stress, and RH incompatibility. In addition, the delivery data obtained included birth weight, fetal sex, Apgar scores, mode of delivery, and any neonatal morbidity or mortality. The use of surfactant during the study period was only in the form of "rescue treatment" based on the presence of hyaline membrane disease (HMD) as defined below.
Major neonatal morbidity was defined as respiratory distress syndrome due to HMD, intraventricular hemorrhage grade III or IV, necrotizing enterocolitis treated surgically, patent ductus arteriosus treated surgically, and retinopathy of prematurity stage III or IV. HMD was defined as the need for supplemental oxygen for Ͼ24 hours, with chest x-ray confirmation revealing a reticulogranular pattern with air bronchogram formation.
Minor morbidity was defined as necrotizing enterocolitis and patent ductus arteriosus treated medically, intraventricular hemorrhage grade I or II, and transient tachypnea of the newborn or retained lung fluid. Transient tachypnea of the newborn or retained lung fluid was defined as a need for supplemental oxygen for Ͻ24 hours, with a chest x-ray that was negative for HMD.
Only patients delivered within 72 hours of testing were analyzed for the incidence of major or minor morbidity. This 72-hour cutoff time was originally chosen by Donald et al. 5 in 1973 and has been used in the majority of comparison studies published to date. 6 -8 All neonatal chest x-rays were re-evaluated by a pediatric radiologist who was blinded to the newborn history. This study was reviewed and approved by the institutional review board. Statistical analysis was performed using the Fisher's exact test and 95% confidence intervals (CIs) for percentage distributions.
RESULTS
During the 9-year study period, Ͼ3500 patients underwent pulmonary maturity testing; of these, 2038 singleton pregnancies had an L/S ratio performed, with 162 (7.9%) preterm pregnancies showing an L/S ratio of 1.8 or 1.9. A total of 99 patients were excluded for the following reasons: 83 patients delivered Ͼ72 hours after obtaining the test, 7 patients had contaminated samples, 5 cases involved the delivery of an anomalous fetus, and 4 patients delivered at a different institution. Therefore, 63 patients met the inclusion criteria. A total of 33 of these patients had an L/S ratio of 1.9, and 30 patients had an L/S ratio of 1.8.
The indications for amniocentesis are seen in Table 1 . Tables 2  and 3 display the gestational ages at the time of amniocentesis in relation to the risk of major or minor morbidity. The risk of major neonatal morbidity in cases with an L/S ratio of 1.8 was 13% with a 95% CI of 4% to 30%. All four newborns were Ͻ34 weeks' gestation, and one of these four cases died for a 3.3% risk of mortality (95% CI of 0% to 17%). The risk of minor morbidity was also 13%. Thus overall, there was a one in four risk of neonatal complications (major and minor) in the 1.8 L/S ratio group.
The risk of major morbidity in the 1.9 L/S ratio group was only 3% (95% CI of 0% to 15%), and there were no mortalities (95% CI of 0% to 9%). The risk of minor morbidity was 9%. The overall risk of neonatal complications in this group (major and minor) was one in eight cases (12.5%).
None of the patients in the 1.9 L/S ratio group received antenatal steroids. However, a total of eight patients (27%) in the 1.8 L/S ratio group were administered antenatal steroids, and one of these patients had major morbidity (13%). The incidence of major morbidity in the 1.8 L/S ratio group without antenatal steroids was 3 in 22 or 14% (95% CI of 4% to 33%). The one neonatal death did not receive antenatal steroids. Table 4 summarizes the five cases with major morbidity and or mortality. As shown, all five developed HMD and all were treated with rescue surfactant. The one death occurred from respiratory complications.
There were 18 patients with cesarean sections in the 1.8 L/S ratio group and 13 cesarean deliveries in the 1.9 L/S ratio group. Overall, there were 31 pregnancies delivered by cesarean section and 32 pregnancies delivered vaginally. The risk of major morbidity was 13% in the cesarean section group versus only 3% in the vaginal delivery group; however, this did not reach significance, with p ϭ 0.17. A similar finding was seen with regard to a male fetus: A total of 36 infants were male, with a risk of 11% (4 of 36 infants) for major 
DISCUSSION
It is well known that early in the third trimester of pregnancy, fetal type II pneumocytes begin to secrete a surface active agent composed primarily of phosphatidylcholine (lecithin) and phosphatidylglycerol. This compound is secreted into lamellar body "packages" and carried into the amniotic fluid by fetal breathing movements, thus allowing for the assessment of fetal lung maturity by amniocentesis. 9 Gluck et al. 1 showed that at ϳ34 weeks' gestation, there is a rapid increase in the amount of lecithin that is secreted by the fetal lung, while the sphingomyelin concentration remains relatively constant. They discovered that when the ratio reached a value of Ն2.0, very few cases of respiratory distress syndrome occurred. The use of this L/S ratio has been extremely helpful in the delivery of patients with uncertain gestational dates, those requiring repeat cesarean sections, and mothers with particular pathologic processes.
Occasionally, clinicians are placed in a precarious position when they are presented with an L/S ratio of 1.8 or 1.9 while managing a high-risk preterm pregnancy. Do they proceed with delivery for the sake of the mother and risk neonatal morbidity or mortality, or do they choose expectant management for the benefit of the fetus and place the mother at potential risk? The purpose of our study was to provide morbidity and mortality information on pregnancies that delivered with L/S ratios of 1.8 or 1.9. In doing this, it was our hope that a more sound risk/benefit decision could be made when faced with this clinical dilemma.
Most prior investigations regarding the L/S ratio and fetal outcome have reported on the relationship of the test result to the incidence of respiratory distress syndrome only. We felt it was necessary to use the L/S ratio as a guideline for overall maturity and evaluate for other significant neonatal complications related to prematurity such as necrotizing enterocolitis, intraventricular hemorrhage, and patent ductus arteriosus.
Prior studies have shown an increase in respiratory complications in male infants and in pregnancies delivered by cesarean section. 2, 5, 6, 10 This was not seen in our study, although this may be due to the small numbers.
One potential concern with this study is the relative appearance of small numbers. However, it is important to recognize that it took 9 years to collect Ͼ2000 high-risk patients who underwent amniocentesis for the purpose of evaluating an L/S ratio to identify 63 patients that had a value of 1.8 or 1.9 and delivered Ͻ72 hours after the test. An obvious solution to this problem would be to carry out a multiinstitutional study. However, the information provided in this report can be used until such a study is performed.
As depicted in Tables 2 and 3 , no major morbidity was seen in the 29 neonates delivered after 34 weeks' gestation. This is another important piece of information that clinicians can use in their decisionmaking process when presented with a borderline immature L/S ratio in a complicated pregnancy beyond 34 weeks' gestation.
Neonatal outcome with an L/S ratio of 1.8 or 1.9 has not been addressed in the literature to date. In a study by Harvey et al., 11 the incidence of respiratory disease was reported as 40% (89 of 223 infants) with an L/S ratio of between 1.5 and 2.0; with this, there was a 4% mortality rate. However, this study was a summary of 25 reports, many of which did not define the type of respiratory disease or the gestational ages of the patients. Lipshitz et al. 6 had 3 of 22 infants (14%) with respiratory distress syndrome in patients with an L/S ratio of 1.5 to 1.9, whereas Herbert et al. 10 reported on 23 patients with L/S ratios of between 1.5 and 2.0 in which no infants suffered from respi- ratory distress. However, the gestational ages of these patients were not well defined. Therefore, the prior literature has touched on the fact that a newborn does have a chance for jeopardy when delivered in the setting of an L/S ratio that is Ͻ2.0 but Ն1.5, but the exact risk for borderline cases (L/S ratios of 1.8 and 1.9) has not been evaluated previously. In summary, in high-risk patients delivered with an L/S ratio of 1.9 (where maturity is set at 2.0), the risk of major neonatal morbidity was only 3%, with a maximum of Յ15% when using the 95% CIs. The risk for mortality was 0, with a maximum of Ͻ10% when using the 95% CI. When delivery occurred with an L/S ratio of 1.8, these risks increased. If time can be gained, patients with a 1.8 L/S ratio might benefit from antenatal steroids depending on gestational age. Until a large multicenter study is performed, these data may help in the decision process when faced with a borderline immature L/S ratio in a complicated pregnancy.
